Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Sarah Walker

Showing results (111-120 of 388) with videos related to

Pageof 39
Sort By:
The Journal of Hospital Infection|April 27, 2025
Timeliness of a potential automated system for national surveillance of healthcare-associated infections in EnglandT Phuong Quan, David W Eyre, Stephanie Shadwell, et al.
The Journal of Infection|August 10, 2019
Predictors of recurrence, early treatment failure and death from Staphylococcus aureus bacteraemia: Observational analyses within the ARREST trialAlexander Szubert, Sarah Lou Bailey, Graham S Cooke, et al.
Antiviral Therapy|October 12, 2007
Transient viral load increases in HIV-infected children in the U.K. and Ireland: what do they mean?Katherine J Lee, Delane Shingadia, Deenan Pillay, et al.
Therapeutic Drug Monitoring|April 14, 2010
Limited sampling models to predict the pharmacokinetics of nevirapine, stavudine, and lamivudine in HIV-infected children treated with pediatric fixed-dose combination tabletsDavid Burger, Fiona Ewings, Desiré Kabamba, et al.
Antiviral Therapy|February 4, 2012
The prevalence of darunavir-associated mutations in HIV-1-infected children in the UKKatherine L Donegan, A Sarah Walker, David Dunn, et al.
The Lancet. Infectious Diseases|April 24, 2021
Personalised randomised controlled trial designs-a new paradigm to define optimal treatments for carbapenem-resistant infectionsA Sarah Walker, Ian R White, Rebecca M Turner, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 23, 2014
Reply to Mills and LinkinJames R Price, Tanya Golubchik, Daniel J Wilson, et al.
The Journal of Infectious Diseases|April 11, 2014
Reduction of invasive pneumococcal disease 3 years after the introduction of the 13-valent conjugate vaccine in the Oxfordshire region of EnglandCatrin E Moore, John Paul, Dona Foster, et al.
BMC Microbiology|March 14, 2014
Prevalence of Staphylococcus aureus protein A (spa) mutants in the community and hospitals in OxfordshireAntonina A Votintseva, Rowena Fung, Ruth R Miller, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 28, 2013
Risk factors for Clostridium difficile acquisition in infants: importance of study designNicole E Stoesser, Jessica Martin, Damian Mawer, et al.
Pageof 39

Showing results (111-120 of 388) with videos related to

Sort By:
Pageof 39
The Journal of Hospital Infection|April 27, 2025
Timeliness of a potential automated system for national surveillance of healthcare-associated infections in EnglandT Phuong Quan, David W Eyre, Stephanie Shadwell, et al.
The Journal of Infection|August 10, 2019
Predictors of recurrence, early treatment failure and death from Staphylococcus aureus bacteraemia: Observational analyses within the ARREST trialAlexander Szubert, Sarah Lou Bailey, Graham S Cooke, et al.
Antiviral Therapy|October 12, 2007
Transient viral load increases in HIV-infected children in the U.K. and Ireland: what do they mean?Katherine J Lee, Delane Shingadia, Deenan Pillay, et al.
Therapeutic Drug Monitoring|April 14, 2010
Limited sampling models to predict the pharmacokinetics of nevirapine, stavudine, and lamivudine in HIV-infected children treated with pediatric fixed-dose combination tabletsDavid Burger, Fiona Ewings, Desiré Kabamba, et al.
Antiviral Therapy|February 4, 2012
The prevalence of darunavir-associated mutations in HIV-1-infected children in the UKKatherine L Donegan, A Sarah Walker, David Dunn, et al.
The Lancet. Infectious Diseases|April 24, 2021
Personalised randomised controlled trial designs-a new paradigm to define optimal treatments for carbapenem-resistant infectionsA Sarah Walker, Ian R White, Rebecca M Turner, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 23, 2014
Reply to Mills and LinkinJames R Price, Tanya Golubchik, Daniel J Wilson, et al.
The Journal of Infectious Diseases|April 11, 2014
Reduction of invasive pneumococcal disease 3 years after the introduction of the 13-valent conjugate vaccine in the Oxfordshire region of EnglandCatrin E Moore, John Paul, Dona Foster, et al.
BMC Microbiology|March 14, 2014
Prevalence of Staphylococcus aureus protein A (spa) mutants in the community and hospitals in OxfordshireAntonina A Votintseva, Rowena Fung, Ruth R Miller, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 28, 2013
Risk factors for Clostridium difficile acquisition in infants: importance of study designNicole E Stoesser, Jessica Martin, Damian Mawer, et al.
Pageof 39